{
    "nct_id": "NCT04548830",
    "official_title": "Safety of Transbronchial Cryobiopsy in a Cancer Population",
    "inclusion_criteria": "* 18 years of age or greater\n* Patients with known or suspected diagnosis of cancer and indeterminant pulmonary nodules or diffuse parenchymal lung disease with non-diagnostic clinical profiles for whom a lung biopsy is deemed useful for diagnosis.\nHealthy volunteers allowed\nMust have minimum age of 18 Years",
    "exclusion_criteria": "* Patients with pulse oximetry less than 92% on oxygen delivery up to 2 L nasal cannula.\n* Uncorrectable coagulopathy defined as:\n\n  * Platelet count <50,000 x 10^9/L or\n  * prothrombin time international normalized ratio >1.5\n* FVC <50% of the predicted value, DLCO <30% of the predicted value or FEV1 <0.8L\n* Known pulmonary hypertension or echocardiographic pulmonary artery systolic pressure >50mmHg\n* A secure diagnosis based on clinical and high-resolution CT scan data.\n* Antiplatelet therapy that cannot be held for more than 5 days.\n* Any patient deemed unfit to undergo bronchoscopy by the proceduralist\n* Female patients with a positive pregnancy test within 30 days of the planned study procedure",
    "miscellaneous_criteria": ""
}